Emicizumab in people with moderate or mild haemophilia an aged ?40 years, with and without - Jimenez-Yuste, V; Tzeng, E; Lim, E; Ventriglia, G; Shapiro, A; Oldenburg, J; Mahlangu, J (HAEMOPHILIA, 2024)